Regeneron Expands Precision Medicine Pipeline With $2.3B Parabilis Collaboration
TARRYTOWN, N.Y., May 18, 2026 Regeneron Pharmaceuticals has announced a major strategic collaboration with Parabilis Medicines valued at up...
AATD
Advertisement
Sanofi’s Efdoralprin Alfa Shows Superior Phase 2 Results in AATD
PARIS, France, May 18, 2026 Sanofi has announced positive Phase 2 ElevAATe trial results demonstrating that investigational therapy efdoralprin...
AIRNA Showcases RNA Editing Advances at ASGCT 2026
CAMBRIDGE, Mass., May 12, 2026 AIRNA announced new preclinical findings at the 2026 American Society of Gene and Cell...
Roche Launches Rapid 15-Minute Bordetella Point-of-Care Test
Basel, Switzerland, December 2, 2025 —Roche has announced the launch of a rapid 15-minute point-of-care PCR test capable of...
Regeneron and Tessera Unite to Develop TSRA-196 Therapy
Tarrytown, New York & Somerville, Massachusetts, December 1, 2025 — Regeneron and Tessera Therapeutics have announced a global collaboration...
Advertisement
